WallStSmart

Hudbay Minerals Inc. (HBM)vsStryker Corporation (SYK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Stryker Corporation generates 965% more annual revenue ($25.27B vs $2.37B). HBM leads profitability with a 27.8% profit margin vs 13.2%. SYK appears more attractively valued with a PEG of 1.39. HBM earns a higher WallStSmart Score of 77/100 (B+).

HBM

Strong Buy

77

out of 100

Grade: B+

Growth: 8.7Profit: 8.5Value: 4.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.39

SYK

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.0
Piotroski: 3/9Altman Z: 2.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HBMSignificantly Overvalued (-71.4%)

Margin of Safety

-71.4%

Fair Value

$15.42

Current Price

$25.02

$9.60 premium

UndervaluedFair: $15.42Overvalued
SYKOvervalued (-10.9%)

Margin of Safety

-10.9%

Fair Value

$265.23

Current Price

$285.47

$20.24 premium

UndervaluedFair: $265.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HBM5 strengths · Avg: 9.0/10
Operating MarginProfitability
40.0%10/10

Strong operational efficiency at 40.0%

EPS GrowthGrowth
91.9%10/10

Earnings expanding 91.9% YoY

Profit MarginProfitability
27.8%9/10

Keeps 28 of every $100 in revenue as profit

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
27.3%8/10

Revenue surging 27.3% year-over-year

SYK1 strengths · Avg: 9.0/10
Market CapQuality
$112.69B9/10

Large-cap with strong market position

Areas to Watch

HBM3 concerns · Avg: 3.0/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.392/10

Distress zone — elevated risk

SYK3 concerns · Avg: 3.7/10
P/E RatioValuation
34.0x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HBM

The strongest argument for HBM centers on Operating Margin, EPS Growth, Profit Margin. Profitability is solid with margins at 27.8% and operating margin at 40.0%. Revenue growth of 27.3% demonstrates continued momentum.

Bull Case : SYK

The strongest argument for SYK centers on Market Cap. PEG of 1.39 suggests the stock is reasonably priced for its growth.

Bear Case : HBM

The primary concerns for HBM are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Bear Case : SYK

The primary concerns for SYK are P/E Ratio, Revenue Growth, Piotroski F-Score.

Key Dynamics to Monitor

HBM profiles as a growth stock while SYK is a value play — different risk/reward profiles.

HBM carries more volatility with a beta of 2.15 — expect wider price swings.

HBM is growing revenue faster at 27.3% — sustainability is the question.

SYK generates stronger free cash flow (415M), providing more financial flexibility.

Bottom Line

HBM scores higher overall (77/100 vs 59/100), backed by strong 27.8% margins and 27.3% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hudbay Minerals Inc.

BASIC MATERIALS · COPPER · USA

Hudbay Minerals Inc., a diversified mining company, focuses on the discovery, production and marketing of base and precious metals in North and South America. The company is headquartered in Toronto, Canada.

Visit Website →

Stryker Corporation

HEALTHCARE · MEDICAL DEVICES · USA

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Visit Website →

Want to dig deeper into these stocks?